Heron Therapeutics, Inc.

HRTX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000818033

SEC filings (opens in a new tab)

No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Heron Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of HRTX: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	189	2	197	+10
Shares	103.9M	570	108.5M	+4.63M (+4.5%)
Value	$1.61B	$9.00K	$1.16B	−$451.2M (−28.0%)

2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Heron Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to HRTX in Q3 2021
Institution	Shares	Value	% of portfolio
KBC Group NV	452,150	$4.83M	0.02%
Magnetar Financial LLC	157,962	$1.69M	0.02%
Ensign Peak Advisors, Inc	123,115	$1.32M	0.00%
Crestline Management, LP	102,845	$1.10M	0.10%
Jump Financial, LLC	70,326	$752.0K	0.05%
Schonfeld Strategic Advisors LLC	50,600	$541.0K	0.01%
SG Americas Securities, LLC	41,535	$444.0K	0.00%
Ergoteles LLC	29,885	$319.0K	0.01%
XTX Topco Ltd	26,811	$287.0K	0.10%
Marshall Wace North America L.P.	26,362	$282.0K	0.00%
Twinbeech Capital LP	18,167	$194.0K	0.01%
E Fund Management Co., Ltd.	14,805	$158.0K	0.01%
Raymond James & Associates	14,081	$151.0K	0.00%
Voloridge Investment Management, LLC	11,933	$128.0K	0.00%
Engineers Gate Manager LP	11,006	$118.0K	0.01%
Mirae Asset Global Investments Co., Ltd.	10,233	$109.0K	0.00%
Newbridge Financial Services Group, Inc.	6,860	$73.0K	0.05%
Reilly Financial Advisors, LLC	4,000	$43.0K	0.00%
Migdal Insurance & Financial Holdings Ltd.	3,420	$37.0K	0.00%
Simplex Trading, LLC	2,006	$30.0K	0.00%
Cahill Financial Advisors Inc	223	$2.00K	0.00%
Ancora Advisors, LLC	50	$1.00K	0.00%
Cordant, Inc.	63	$1.00K	0.00%
Smith Group Asset Management, LLC	120	$1.00K	0.00%

Sold out (14)

Institutions that held Heron Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of HRTX in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Kettle Hill Capital Management, LLC	372,199	$5.78M
Millennium Management LLC	327,721	$5.09M
Jacobs Levy Equity Management, Inc	295,276	$4.58M
State of New Jersey Common Pension Fund D	176,710	$2.74M
Caas Capital Management LP	175,333	$2.72M
Russell Investments Group, Ltd.	129,458	$2.01M
Centiva Capital, LP	17,296	$268.0K
Beirne Wealth Consulting Services, LLC	12,500	$196.0K
Capula Management Ltd	10,105	$157.0K
Group One Trading, L.P.	7,721	$120.0K
STRS Ohio	6,100	$94.0K
Toth Financial Advisory Corp	85	$1.00K
Quadrant Capital Group LLC	33	$1.00K
BDO Wealth Advisors, LLC	50	$1.00K

Not filed for Q3 2021 yet (2)

Institutions that held Heron Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HRTX in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
CWM, LLC	450	$7.00K
Smith Asset Management Group LP	120	$2.00K